CS408391A3 - Novel peptides active on central neural system and cholinergic system - Google Patents

Novel peptides active on central neural system and cholinergic system

Info

Publication number
CS408391A3
CS408391A3 CS914083A CS408391A CS408391A3 CS 408391 A3 CS408391 A3 CS 408391A3 CS 914083 A CS914083 A CS 914083A CS 408391 A CS408391 A CS 408391A CS 408391 A3 CS408391 A3 CS 408391A3
Authority
CS
Czechoslovakia
Prior art keywords
novel peptides
cholinergic
central neural
peptides active
denotes
Prior art date
Application number
CS914083A
Other languages
English (en)
Inventor
Rolf Geiger
Hermann Gerhards
Hansjorg Kruse
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CS408391A3 publication Critical patent/CS408391A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS914083A 1984-10-22 1991-12-27 Novel peptides active on central neural system and cholinergic system CS408391A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/663,193 US4623715A (en) 1984-10-22 1984-10-22 Novel peptides which are active on the central nervous system and have an action on the cholinergic system

Publications (1)

Publication Number Publication Date
CS408391A3 true CS408391A3 (en) 1992-06-17

Family

ID=24660834

Family Applications (1)

Application Number Title Priority Date Filing Date
CS914083A CS408391A3 (en) 1984-10-22 1991-12-27 Novel peptides active on central neural system and cholinergic system

Country Status (13)

Country Link
US (2) US4623715A (cs)
EP (1) EP0179332B1 (cs)
JP (1) JPH075632B2 (cs)
AT (1) ATE84544T1 (cs)
AU (1) AU579593B2 (cs)
CA (1) CA1267996A (cs)
CS (1) CS408391A3 (cs)
DE (1) DE3586979D1 (cs)
DK (1) DK170649B1 (cs)
ES (1) ES8703488A1 (cs)
GR (1) GR852541B (cs)
IE (1) IE59724B1 (cs)
PT (1) PT81345B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565606A (en) * 1986-10-21 1996-10-15 Hoechst Aktiengesellschaft Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
ATE63821T1 (de) * 1987-08-14 1991-06-15 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
US4945999A (en) * 1989-04-06 1990-08-07 The Charles Machine Works, Inc. Directional rod pusher
DE3931788A1 (de) * 1989-09-23 1991-04-04 Hoechst Ag Neue zns-aktive hexapeptide mit antiamnestischer wirkung
ZA914684B (en) * 1990-07-18 1992-04-29 Akzo Nv Use of a centrally acting acth analog in the manufacture of a medicament
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US5190924A (en) * 1991-02-13 1993-03-02 Boc Health Care, Inc. Peptide amides and amide dimers useful as muscle relaxants
US7176279B2 (en) * 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
GB0010183D0 (en) * 2000-04-26 2000-06-14 Ferring Bv Inhibitors of dipeptidyl peptidase IV
AU2002359364A1 (en) * 2001-11-09 2003-05-26 Enzon, Inc. Polymeric thiol-linked prodrugs employing benzyl elimination systems
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
CA2939164A1 (en) 2014-02-12 2015-08-20 Iteos Therapeutics Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042064A (en) * 1957-04-02 1962-07-03 Rockwell Mfg Co Gas pressure regulator
BE795788A (nl) 1972-02-22 1973-08-22 Akzo Nv Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
US3856770A (en) 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
NL7607684A (nl) 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
IE56254B1 (en) 1982-11-10 1991-06-05 Akzo Nv Peptides

Also Published As

Publication number Publication date
PT81345B (pt) 1987-12-30
EP0179332B1 (de) 1993-01-13
ES548052A0 (es) 1987-02-16
JPS61100596A (ja) 1986-05-19
AU579593B2 (en) 1988-12-01
US4623715A (en) 1986-11-18
ES8703488A1 (es) 1987-02-16
ATE84544T1 (de) 1993-01-15
AU3539484A (en) 1986-05-01
IE852596L (en) 1986-04-22
PT81345A (de) 1985-11-01
EP0179332A3 (en) 1989-02-08
JPH075632B2 (ja) 1995-01-25
US4696913A (en) 1987-09-29
DE3586979D1 (de) 1993-02-25
CA1267996A (en) 1990-04-17
GR852541B (cs) 1986-02-18
DK482185D0 (da) 1985-10-21
IE59724B1 (en) 1994-03-23
DK170649B1 (da) 1995-11-20
DK482185A (da) 1986-04-23
EP0179332A2 (de) 1986-04-30

Similar Documents

Publication Publication Date Title
ES8704973A1 (es) Un procedimiento para la preparacion de un peptido.
DE3785388D1 (de) Antivirale peptide und mittel zur behandlung von herpes.
EP0166612A3 (en) Potent thymopentin analogs
CS408391A3 (en) Novel peptides active on central neural system and cholinergic system
NZ215096A (en) Renin inhibiting peptide derivatives, pepstatin analogues
DE3582895D1 (de) Peptid, dessen herstellung und benutzung.
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
IT8319160A0 (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi.
CA2094347A1 (en) A method of producing a factor viii preparation
ES8404514A1 (es) Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad
EP0264953A3 (en) Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
NZ229401A (en) Protein extracted from 'hard ticks' having thrombin-inhibitary action
HUT54367A (en) Process for producing 2-aza-bicyclo(2.2.1)hept-5-en-2-yl-acetic acid and n-(phosphono-methyl)-glycine
ES8308305A1 (es) Procedimiento para la preparacion de un peptido.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
EP0248231A3 (en) Pharmacologically active peptides
ATE46173T1 (de) Pharmakologisch aktive peptide.
EP0296227A4 (en) ADMINISTRATION OF AMINOACIDS BY NASAL ROUTE.
JPS5775960A (en) Purified polypeptide
IE891398L (en) Acid addition salts of amidated taurine or glycine
IT8419056A0 (it) Procedimento per l'isolamento di l-amminoacidi.